If you have a rotator cuff tear, you may have heard about “stem cell” treatments and wondered whether they could heal your shoulder without surgery. It’s a reasonable question, and the honest answer is a mix of genuine promise and important caution. This article walks you through what these treatments are, how they are being used, where the science currently stands, and what you can realistically expect.

What the rotator cuff is and why tears are hard to heal

The rotator cuff is a group of four muscles and their tendons that wrap around the top of your arm bone and hold it securely in the shoulder socket. These tendons let you lift, reach, and rotate your arm. As we age, the tendons can fray, thin, or tear — sometimes from a specific injury, but often simply from years of wear. Once a tendon is torn or degenerated, the body’s natural ability to repair it is limited, which is why some tears cause ongoing pain and weakness.

This healing problem is exactly what stem cell therapy is trying to solve.

What “stem cells” actually means in this setting

The term “stem cells” is used loosely in advertising, so it helps to be precise. In shoulder treatment, the cells most often used are mesenchymal stem cells (MSCs) — a type of repair cell your body already has. They are usually collected from one of two places in your own body:

• Bone marrow, drawn from the pelvis and concentrated into what is called bone marrow aspirate concentrate (BMAC).

• Fat (adipose) tissue, collected through a small liposuction-type procedure and processed into “adipose-derived” cells.

The idea is that these cells, when delivered to the injured tendon, may reduce inflammation and encourage the tissue to regenerate rather than simply scar over.

How stem cells are thought to work

It’s natural to picture injected stem cells “turning into” new tendon. The reality is more subtle, and understanding it helps set expectations. For many years scientists assumed MSCs mainly homed to the injury and rebuilt it by becoming new tendon cells. Research now suggests that only a small fraction of injected cells survive and stay in place — in one animal study, just a few percent of labeled cells remained a month after injection (Yea et al., PLoS One, 2020). Instead, most of the benefit appears to come from the chemical signals these cells release. They can calm inflammation, discourage scar formation, stimulate the body’s own repair cells, and encourage new blood vessel growth and healthy collagen (Andia and Maffulli, Sports Medicine, 2017; Jenner et al., American Journal of Sports Medicine, 2023).

This “signaling” role is why newer research is even exploring the fluid and tiny packets (called exosomes) that stem cells secrete, rather than the cells themselves (Jenner et al., American Journal of Sports Medicine, 2023). That work is still in the laboratory and animal stage, but it explains an important point for patients: this is biology we are still learning to harness, not a simple spare-part swap.

How stem cells are being used today

There are two very different ways these cells are being applied, and it’s important not to confuse them:

• As an injection into or around the tendon, without surgery. This is the “non-surgical regenerative” approach many patients are curious about, typically for partial-thickness (incomplete) tears (Jo et al., Arthroscopy, 2020).

• As an add-on during rotator cuff surgery, where the cells are applied to the repair site to try to improve healing and lower the chance of the tendon re-tearing (Cole et al., American Journal of Sports Medicine, 2023).

Most of the published research actually falls into the second category — stem cells used to support a surgical repair, rather than to replace it (Di Matteo et al., Stem Cells International, 2021).

What the outcomes have shown so far

Some early results are encouraging. In a small study of patients with partial-thickness tears who received an injection of their own fat-derived stem cells directly into the tendon, shoulder pain dropped by roughly 90% at one and two years, strength improved, and MRI scans showed the tendon defects shrinking, with no treatment-related serious side effects over two years (Jo et al., Arthroscopy, 2020). In another study of partial-thickness tears, fat-derived cells produced better shoulder function and pain scores than a cortisone injection, and appeared safe over several years of follow-up (Lundeen et al., Scientific Reports, 2023).

But the encouraging early studies share an important weakness: they had no comparison group, so natural healing and the placebo effect could not be ruled out. When researchers ran a more rigorous test — a randomized trial comparing stem cell injection against placebo injections for partial supraspinatus tears — the stem cell group did not improve more than the control groups at three months (Chun et al., Scientific Reports, 2022). This kind of head-to-head, placebo-controlled study is the gold standard, and its neutral result is a key reason for caution.

When used during surgery, bone marrow concentrate has shown better tendon healing and structural integrity on imaging at one year compared with surgery alone (Cole et al., American Journal of Sports Medicine, 2023). The most striking long-term data come from a single team: in their work, cuff repairs augmented with bone marrow stem cells were 100% healed at six months versus 67% with surgery alone, and at ten years 87% remained intact versus 44% — with higher cell concentrations linked to better healing (Nelson et al., American Journal of Sports Medicine, 2024; Di Matteo et al., Stem Cells International, 2021). These results are impressive but have not yet been reproduced by other groups, partly because U.S. regulations limit this kind of study (Nelson et al., American Journal of Sports Medicine, 2024).

The important limitations

This is where realistic expectations matter. Despite the encouraging signals, the overall evidence is still early and far from conclusive:

• The studies are small and short. Many involve only a few dozen patients, and few follow patients beyond one to two years (Di Matteo et al., Stem Cells International, 2021).

• Better scans don’t always mean a better shoulder. Improved tendon healing on MRI has not consistently matched how patients actually feel or function (Cole et al., American Journal of Sports Medicine, 2023).

• The product is not standardized. The number and quality of cells obtained vary a great deal from person to person and from one preparation method to another, so two patients receiving “stem cells” may not be getting the same thing (Di Matteo et al., Stem Cells International, 2021).

• Larger, rigorous trials are lacking. High-quality, placebo-controlled studies — the kind needed to prove a treatment truly works — have not yet confirmed a benefit.

For these reasons, major medical sources currently state that regenerative treatments including stem cells are not recommended as a standard treatment for rotator cuff disorders, because strong trial evidence supporting them is still missing (Jain and Khazzam, New England Journal of Medicine, 2024). A sports medicine society position statement likewise concludes that the true effectiveness of stem cells for tendon problems remains unknown and that more study is needed (Finnoff et al., American Medical Society for Sports Medicine, 2021).

A word about regulation and safety

In the United States, genuinely “expanded” stem cells — cells grown and multiplied in a laboratory — are tightly regulated, and most clinics cannot legally provide them outside of an approved research study (Baker et al., American Journal of Sports Medicine, 2025). What is usually offered instead is same-day processing of your own bone marrow or fat, which is a very different product from the lab-grown cells used in some of the most promising research. This distinction matters when a clinic advertises “stem cells,” because the treatment you receive may contain far fewer and less potent cells than the headlines suggest.

Safety, encouragingly, has been consistent across studies: using your own tissue has not been linked to serious treatment-related complications, and surgical augmentation studies report no added complications (Jo et al., Arthroscopy, 2020; Carola et al., Arthroscopy, 2024). The main concern is not harm — it is paying for a treatment whose benefit is still unproven. Rare complications have, however, been reported with contaminated laboratory-cultured cell products, which is another reason the lab-grown versions are so carefully controlled (Baker et al., American Journal of Sports Medicine, 2025).

Important clarification: small studies cannot establish that a procedure is risk-free. Harvesting and injection can cause pain, bleeding, infection, and other complications. Same-day processing does not automatically mean a product is FDA-approved or exempt from regulation; requirements depend on the product, processing, and intended use. BMAC is a mixed concentrate, not a standardized dose of purified stem cells.

Questions worth asking before you decide

• What does it cost, and what happens if it doesn’t work? Clarify the out-of-pocket price and the backup plan.

• Is my tear partial or full-thickness? This strongly shapes whether an injection is even a reasonable option.

Practical things to keep in mind

• These treatments are usually not covered by insurance and are often paid for out of pocket.

• Marketing can outpace the science. Be cautious of clinics promising guaranteed regeneration or tear “reversal.”

• A complete (full-thickness) tear is unlikely to be fixed by an injection alone. Stem cell injections have mostly been studied in partial tears; a large full-thickness tear generally still requires surgical repair.

• Safety so far looks reasonable. In the studies to date, using your own cells has not caused serious treatment-related complications, which is reassuring even as the effectiveness question remains open (Jo et al., Arthroscopy, 2020; Lundeen et al., Scientific Reports, 2023).

The bottom line for patients

Stem cell therapy for rotator cuff tears is a genuinely promising area, and some patients with partial tears have done well in early studies. But it is still experimental, not standardized, often not covered by insurance, and not yet proven superior to established treatments in large, high-quality trials. For now it is best thought of as an option to discuss carefully and individually — not as a proven substitute for the treatments we know work, including structured physical therapy and, when appropriate, surgical repair.

If you are curious whether stem cell therapy might fit your specific tear and goals, bring it up at your next visit so we can review your imaging and talk through the realistic options together.

Rotator cuff treatment in Dallas, Plano, and DFW

Dr. Eric Sanders provides individualized shoulder evaluation and treatment planning for patients in Dallas, Plano, and the greater DFW metroplex. Discussing your imaging, activity goals, and response to rehabilitation can help put emerging treatments in context alongside established non-surgical and surgical options.

This article is for general education and does not replace a personal medical evaluation. Treatment recommendations should be based on an examination and appropriate imaging.

Rotator cuff repair in Dallas

Partial vs. full-thickness rotator cuff tears

PRP vs. cortisone for rotator cuff pain

Schedule an evaluation or request a second opinion